evaxion-biotech.com (EVAX) - Amount of Cash per Share

Evaxion Biotech AS - graphic logo of issuer EVAX

The success of Evaxion Biotech A/S (EVAX) depends on the precision of AI algorithms and patent protection. Cash per share for the period demonstrates financial stability, where 1.67 captures the current value of the indicator. The company's visionary image in science, along with payments from pharma behemoths and the development of personalized vaccines, mitigates risks and strengthens the issuer's position.

Evaxion (EVAX) - Cash per Share from 07/04/2022 to 11/20/2026

Comprehensive metric breakdowns and analytics for Evaxion Biotech AS (EVAX)

- stock value and consensus price forecast:
- cash availability and cash flow indicators:
General company analysis:Evaxion Biotech Corp
Manufactured product of Evaxion Biotech Corp

Cash per share measures the volume of liquid reserves attributable to a single security, reflecting the business's actual solvency. For Evaxion Biotech A/S (EVAX), this resource is critical when integrating bioinformatics and AI into vaccine development. By analyzing the cash per share history, an investor can observe the operational dynamics of cash flows. Growth in this metric confirms financial stability and the confidence of funds, serving as the foundation for the company's long-term development.